Bantu Tanzanians have a decreased capacity to metabolize omeprazole and mephenytoin in relation to their CYP2C19 genotype (Q43952641)

28 November 2017

Bantu Tanzanians have a decreased capacity to metabolize omeprazole and mephenytoin in relation to their CYP2C19 genotype (English)

1 reference

28 November 2017

0 references

1 reference

11

1 reference

28 November 2017

K Herrlin

1

1 reference

28 November 2017

A Y Massele

2

1 reference

28 November 2017

M Jande

3

1 reference

28 November 2017

C Alm

4

1 reference

28 November 2017

G Tybring

5

1 reference

28 November 2017

Y A Abdi

6

1 reference

28 November 2017

A Wennerholm

7

1 reference

28 November 2017

I Johansson

8

1 reference

28 November 2017

M L Dahl

9

1 reference

28 November 2017

L Bertilsson

10

1 reference

28 November 2017

language of work or name

English

0 references

publication date

1 October 1998

1 reference

Clinical Pharmacology & Therapeutics

28 November 2017

1 reference

28 November 2017

64

1 reference

28 November 2017

4

1 reference

28 November 2017

391-401

1 reference

The activation of the biguanide antimalarial proguanil co-segregates with the mephenytoin oxidation polymorphism--a panel study

28 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990070-4

Interphenotype differences in disposition and effect on gastrin levels of omeprazole--suitability of omeprazole as a probe for CYP2C19

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990070-4

Limitation to the use of the urinary S-/R-mephenytoin ratio in pharmacogenetic studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990070-4

Identification of human liver cytochrome P450 isoforms mediating omeprazole metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990070-4

Interactions of ingested food, beverage, and tobacco components involving human cytochrome P4501A2, 2A6, 2E1, and 3A4 enzymes

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990070-4

Geographical/interracial differences in polymorphic drug oxidation. Current state of knowledge of cytochromes P450 (CYP) 2D6 and 2C19

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990070-4

Slow omeprazole metabolizers are also poor S-mephenytoin hydroxylators.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990070-4

Importance of genetic factors in the regulation of diazepam metabolism: relationship to S-mephenytoin, but not debrisoquin, hydroxylation phenotype.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990070-4

The mephenytoin oxidation polymorphism is partially responsible for the N-demethylation of imipramine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990070-4

Pharmacokinetics of citalopram in relation to the sparteine and the mephenytoin oxidation polymorphisms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990070-4

CYP2C19 genotype and phenotype determined by omeprazole in a Korean population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990070-4

Mephenytoin hydroxylation deficiency in Caucasians: frequency of a new oxidative drug metabolism polymorphism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990070-4

The hydroxylation of omeprazole correlates with S-mephenytoin metabolism: a population study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990070-4

Variability in the metabolism of proguanil to the active metabolite cycloguanil in healthy Kenyan adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990070-4

S-mephenytoin hydroxylation phenotype and CYP2C19 genotype among Ethiopians

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990070-4

Phenotyping and genotyping of S-mephenytoin hydroxylase (cytochrome P450 2C19) in a Shona population of Zimbabwe

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990070-4

S-mephenytoin hydroxylation phenotypes in a Swedish population determined after coadministration with debrisoquin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990070-4

Direct enantiomeric resolution of mephenytoin and its N-demethylated metabolite in plasma and blood using chiral capillary gas chromatography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990070-4

Determination of omeprazole and metabolites in plasma and urine by liquid chromatography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990070-4

Enantioselective hydroxylation of omeprazole catalyzed by CYP2C19 in Swedish white subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990070-4

Interethnic differences in omeprazole metabolism in the two S-mephenytoin hydroxylation phenotypes studied in Caucasians and Orientals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990070-4

Lack of effect of chloroquine on the debrisoquine (CYP2D6 and S-mephenytoin (CYP2C19) hydroxylation phenotypes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990070-4

Hydroxylation polymorphisms of debrisoquine and mephenytoin in European populations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990070-4

Phenocopies of poor metabolizers of omeprazole caused by liver disease and drug treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990070-4

Chloroguanide metabolism in relation to the efficacy in malaria prophylaxis and the S-mephenytoin oxidation in Tanzanians.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990070-4

Drug-food interactions in hospitalised patients. Methods of prevention

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990070-4

Cooperativity in oxidations catalyzed by cytochrome P450 3A4.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990070-4

The kinetics of aflatoxin B1 oxidation by human cDNA-expressed and human liver microsomal cytochromes P450 1A2 and 3A4.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990070-4

A distribution study of CYP1A2 phenotypes among smokers and non-smokers in a cohort of healthy Caucasian volunteers.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990070-4

Polymorphic hydroxylation of S-mephenytoin and omeprazole metabolism in Caucasian and Chinese subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990070-4

7 January 2021

inferred from DOI database lookup

Identifiers

DOI

10.1016/S0009-9236(98)90070-4

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/5crpn2e4hvf3pdvzm4qptjzzsm

30 July 2022

mapped directly with Wikidata item

Fatcat ID

release_5crpn2e4hvf3pdvzm4qptjzzsm

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/5crpn2e4hvf3pdvzm4qptjzzsm

30 July 2022

mapped directly with Wikidata item

1 reference

https://api.fatcat.wiki/v0/release/5crpn2e4hvf3pdvzm4qptjzzsm

30 July 2022